Enhanced Genomics raised €16M in a Series A round in Sep 2025. The company is based in Cambridge, UK. Investors in the round: BGF, Meltwind, Parkwalk. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €16M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
